Vibrio cholerae infection (cholera)
Cholera is caused by Vibrio cholerae serotypes O1 and O139. Infection is usually acquired overseas (eg in returned travellers) in countries with inadequate access to clean water and sanitation and, rarely, from consumption of imported seafood from endemic areas.
The mainstay of treatment for cholera is rehydration. Antibiotic therapy reduces the volume and duration of diarrhoea; considerCenters for Disease Control and Prevention ((CDC), 2022Kanungo, 2022:
1azithromycin 1 g (child: 20 mg/kg up to 1 g) orally, as a single dose azithromycin azithromycin azithromycin
OR
1ciprofloxacin 1 g (child: 20 mg/kg up to 1 g) orally, as a single dose12. For dosage adjustment in adults with kidney impairment, see ciprofloxacin oral dosage adjustment ciprofloxacin ciprofloxacin ciprofloxacin
OR
1doxycycline orally, as a single dose34 doxycycline doxycycline doxycycline
adult and child 12 years or older: 300 mg
children younger than 12 years: 4 mg/kg up to 300 mg.
Antibiotic-resistant strains of V. cholerae are now common in some regions. In the event of clinical failure, treatment should be guided by the results of susceptibility testing.
An oral cholera vaccine is available and is recommended for travellers who have a high risk of exposure; for more information see the Australian Immunisation Handbook.